Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Autonomous Technology & Robotics ETF (ARKQ) vs Axogen Inc (AXGN) Price & Performance

ARK Autonomous Technology & Robotics ETFTrade
Axogen IncTrade

Price performance (Past 24H)

Key statistics

ARK Autonomous Technology & Robotics ETF vs Axogen Inc — how do they compare? ARK Autonomous Technology & Robotics ETF trades at $120.96, while Axogen Inc trades at $39.93 (market cap $2.16B). The key difference: Axogen Inc is trading nearer its 52-week high, ARK Autonomous Technology & Robotics ETF nearer its low. Which is the better fit depends on your goals.

ARKQAXGN
Sector
Sector/ThematicTechnology
52-Week High
$143.82$46.19
52-Week Low
$91.86$11.28
Market Cap
$2.16B
Enterprise Value
$2.08B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Autonomous Technology & Robotics ETF

ARKQ trades at $123.99, down 0.57% with a bearish technical signal from moving averages. The ETF focuses on autonomous technology and robotics, benefiting from AI momentum with 57% gains since Q1 2026. Support levels cluster around $122-124 while resistance sits at $126-128. Recent news highlights China's EV targets and humanoid robotics growth projections reaching $200 billion by 2035.

The ETF shows strong momentum in AI and robotics themes but carries premium valuations with a 36x P/E ratio. Key risks include sector concentration and dependency on technological adoption rates. Institutional interest remains strong with $2.7 billion in assets, though technical indicators suggest near-term consolidation pressure.

Axogen Inc

AXGN trades at $40.58, down 6.97% today, with neutral technical signals and mixed earnings performance. The company maintains strong gross margins of 75.01% but reported a net loss of $15.70 million in 2025. Analyst sentiment remains overwhelmingly positive with 16 buy ratings and a $47.60 consensus price target, representing 17% upside potential from current levels.

While AXGN shows promising revenue growth and institutional support, persistent net losses and recent earnings misses create execution risk. The stock's valuation appears stretched with a P/S ratio of 8.12 despite negative profitability metrics. Positive reimbursement developments and nerve repair market expansion provide growth catalysts if the company can achieve sustained profitability.

Returns comparison

Trailing returns across standard periods

About ARK Autonomous Technology & Robotics ETF

ARKQ is an actively managed ETF that invests in autonomous technology and robotics. It focuses on disruptive innovations like autonomous mobility, electric vehicles, 3D printing, and energy storage, with holdings such as Tesla and Teradyne.

Read more on ARKQ

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN